GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » E10

Access Bio (XKRX:950130) E10 : ₩1,575.14 (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Access Bio E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Access Bio's adjusted earnings per share data for the three months ended in Jun. 2024 was ₩40.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩1,575.14 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Access Bio's average E10 Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-09-21), Access Bio's current stock price is ₩6340.00. Access Bio's E10 for the quarter that ended in Jun. 2024 was ₩1,575.14. Access Bio's Shiller PE Ratio of today is 4.03.

During the past 12 years, the highest Shiller PE Ratio of Access Bio was 13.20. The lowest was 3.99. And the median was 5.89.


Access Bio E10 Historical Data

The historical data trend for Access Bio's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio E10 Chart

Access Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1,542.66 1,537.12

Access Bio Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,611.32 1,591.53 1,537.12 1,567.43 1,575.14

Competitive Comparison of Access Bio's E10

For the Diagnostics & Research subindustry, Access Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Access Bio's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Access Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Access Bio's Shiller PE Ratio falls into.



Access Bio E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Access Bio's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=40/132.5538*132.5538
=40.000

Current CPI (Jun. 2024) = 132.5538.

Access Bio Quarterly Data

per share eps CPI Adj_EPS
201409 10.000 100.428 13.199
201412 -12.300 99.070 -16.457
201503 -11.000 99.621 -14.636
201506 11.000 100.684 14.482
201509 34.000 100.392 44.893
201512 11.000 99.792 14.611
201603 24.000 100.470 31.664
201606 24.000 101.688 31.285
201609 12.000 101.861 15.616
201612 -46.000 101.863 -59.860
201703 -46.000 102.862 -59.278
201706 -46.000 103.349 -58.999
201709 -34.000 104.136 -43.278
201712 -125.000 104.011 -159.302
201803 -11.000 105.290 -13.848
201806 -22.000 106.317 -27.429
201809 -22.000 106.507 -27.380
201812 -110.000 105.998 -137.559
201903 -45.000 107.251 -55.617
201906 -92.000 108.070 -112.844
201909 -430.000 108.329 -526.156
201912 -25.000 108.420 -30.565
202003 -24.000 108.902 -29.213
202006 12.000 108.767 14.624
202009 60.000 109.815 72.424
202012 1,319.730 109.897 1,591.814
202103 3,309.000 111.754 3,924.861
202106 -604.000 114.631 -698.434
202109 532.000 115.734 609.315
202112 1,824.000 117.630 2,055.421
202203 7,362.000 121.301 8,044.955
202206 1,812.000 125.017 1,921.242
202209 -457.000 125.227 -483.740
202212 -24.000 125.222 -25.405
202303 1,123.000 127.348 1,168.908
202306 -738.000 128.729 -759.929
202309 -208.000 129.860 -212.316
202312 -377.000 129.419 -386.131
202403 80.000 131.776 80.472
202406 40.000 132.554 40.000

Add all the adjusted EPS together and divide 10 will get our e10.


Access Bio  (XKRX:950130) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Access Bio's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6340.00/1575.14
=4.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Shiller P/E Ratio of Access Bio was 13.20. The lowest was 3.99. And the median was 5.89.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Access Bio E10 Related Terms

Thank you for viewing the detailed overview of Access Bio's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Access Bio Business Description

Traded in Other Exchanges
N/A
Address
65 Clyde Road, Suite A, Somerset, NJ, USA, 08873
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio Headlines

No Headlines